Publications & Works

Publication Network

Published journal articles indexed by SCI, SSCI, and AHCI

Chronic thromboembolic pulmonary hypertension in patients with persistent chest symptoms after acute pulmonary embolism

Sahutoglu E., Tuncay E., Aras G., Yenturk E., Kanmaz D., Ongen H. G., et al.
ANATOLIAN JOURNAL OF CARDIOLOGY , vol.25, no.1, pp.24-29, 2021 (SCI-Expanded) identifier identifier identifier

Comparison of Different Pulmonary Hypertension Screening Algorithms in Patients with Systemic Sclerosis

Erdogan M., Avci B. K., Ersoy Y., Ebren C., Ongen Z., Ongen G., et al.
ARTHRITIS & RHEUMATOLOGY , vol.71, 2019 (SCI-Expanded) identifier

What should be the appropriate minimal duration for patient examination and evaluation in pulmonary outpatient clinics?

Musellim B., Borekci S., Uzan G., Sak Z. H. A., Ozdemir S. K., Altinisik G., et al.
ANNALS OF THORACIC MEDICINE , vol.12, no.3, pp.177-182, 2017 (SCI-Expanded) identifier identifier identifier

RELATIONSHIP BETWEEN ABNORMALITIES ON HIGH-RESOLUTION COMPUTERIZED TOMOGRAPHY, PULMONARY FUNCTION, AND BRONCHOALVEOLAR LAVAGE IN PROGRESSIVE SYSTEMIC SCLEROSIS

Cakmak G., Can T. S., Gungogdu S., Akman C., Ikitimur H., Musellim B., et al.
SARCOIDOSIS VASCULITIS AND DIFFUSE LUNG DISEASES , vol.33, no.4, pp.349-354, 2016 (SCI-Expanded) identifier identifier identifier

MALIGNANCIES IN RHEUMATOID ARTHRITIS PATIENTS TREATED WITH TNF-ALPHA ANTAGONISTS

Ozguler Y., Esatoglu S. N., Keskin D., Hatemi G., Hamuryudan V., Pala A. S., et al.
ANNALS OF THE RHEUMATIC DISEASES , vol.74, pp.1040, 2015 (SCI-Expanded) identifier

HOW CORRECT ARE THE ASSUMPTIONS MADE DURING THE DEVELOPMENT OF TUBERCULOSIS SCREENING ALGORYTHMS BEFORE TNF-ALPHA ANTAGONISTS?

Hacioglu A., Ozguler Y., Borekci S., Hamuryudan V., Kecebas H., Tascilar E., et al.
ANNALS OF THE RHEUMATIC DISEASES , vol.74, pp.702, 2015 (SCI-Expanded) Sustainable Development identifier

Borekci S,Atahan E,Yilmaz DD,Mazican N,Duman B,Ozguler Y, et al., "Factors Affecting the Tuberculosis Risk in Patients Receiving Anti-Tumor Necrosis Factor-alpha Treatment"

ÖNGEN H.
RESPIRATION , vol.90, pp.191-198, 2015 (SCI-Expanded) Sustainable Development

How Correct Are the Assumptions Made for Tuberculosis Screening Algorythms before TNF-Alpha Antagonists?

Hacioglu A., Ozguler Y., Borekci S., Hamuryudan V., Kecebas H. D., Tascilar E. K., et al.
ARTHRITIS & RHEUMATOLOGY , vol.66, 2014 (SCI-Expanded) Sustainable Development identifier

Efficacy and safety of nintedanib in idiopathic pulmonary fibrosis

ÖNGEN H.
NEW ENGLAND JOURNAL OF MEDICINE , vol.29, no.370, pp.2071-2082, 2014 (SCI-Expanded) Sustainable Development

Edoxaban versus warfarin for the treatment of symptomatic venous thromboembolism. Hokusai-VTE Investigators

ÖNGEN H.
NEW ENGLAND JOURNAL OF MEDICINE , vol.10, no.369, pp.1406-1015, 2013 (SCI-Expanded)

The relationship between smoking habit and tuberculosis in patients under anti-TNF-alpha treatment

Borekci S., Duman B., Mazican N., Atahan E., Musellim B., Ongen G., et al.
EUROPEAN RESPIRATORY JOURNAL , vol.42, 2013 (SCI-Expanded) Sustainable Development identifier

Riociguat for the treatment of pulmonary arterial hypertension.

ÖNGEN H.
NEW ENGLAND JOURNAL OF MEDICINE , vol.369, no.4, pp.330-340, 2013 (SCI-Expanded)

A Retrospective Case-Control Study, Factors Affecting Treatment Outcomes for Pulmonary Tuberculosis in Istanbul, Turkey

BABALIK A., Kilicaslan Z., KIZILTAS S., GENCER S., Ongen G.
BALKAN MEDICAL JOURNAL , vol.30, no.2, pp.204-210, 2013 (SCI-Expanded) Sustainable Development identifier identifier identifier

THE COST-OF-DISEASE OF DEEP VENOUS THROMBOSIS AND ITS SHORT- AND LONG-TERM CLINICAL CONSEQUENCES IN TURKEY: AN EXPERT PANEL APPROACH FOR ESTIMATION OF COSTS

Deger C., Ozdemir O., Bozkurt K., Demir M., Ince B., Kultursay H., et al.
VALUE IN HEALTH , vol.16, no.3, 2013 (SCI-Expanded) identifier

THE COST-EFFECTIVENESS OF RIVAROXABAN FOR THE PREVENTION OF STROKE IN PATIENTS WITH ATRIAL FIBRILLATION (AF) IN TURKEY

Marmarali B., Ozdemir O., Bozkurt K., Demir M., Ince B., Kultursay H., et al.
VALUE IN HEALTH , vol.16, no.3, 2013 (SCI-Expanded) identifier

THE COST-EFFECTIVENESS OF RIVAROXABAN COMPARED TO ENOXAPARIN PLUS ADJUSTED-DOSE WARFARIN FOR THE TREATMENT OF DEEP VENOUS THROMBOSIS (DVT) IN TURKEY

Parali E., Ozdemir O., Bozkurt K., Demir M., Ince B., Kultursay H., et al.
VALUE IN HEALTH , vol.16, no.3, 2013 (SCI-Expanded) identifier

THE COST-OF-DISEASE OF THROMBOEMBOLIC AND HEMORRHAGIC COMPLICATIONS ASSOCIATED WITH ATRIAL FIBRILLATION AND ITS TREATMENT IN TURKEY: AN EXPERT PANEL APPROACH FOR ESTIMATION OF COSTS

Deger C., Ozdemir O., Bozkurt K., Demir M., Ince B., Kultursay H., et al.
VALUE IN HEALTH , vol.16, no.3, 2013 (SCI-Expanded) identifier

Pulmonary tuberculosis incidence in Turkish prisons: importance of screening and case finding strategies.

Öngen G., BOREKCI S., İÇMELI Ö., BIRGEN N., KARAGÜL G., AKGÜN S., et al.
Tuberkuloz ve toraks , vol.61, pp.21-7, 2013 (SCI-Expanded) Sustainable Development identifier identifier

COST ANALYSIS OF VENOUS THROMBOEMBOLISM PROPHYLAXIS AFTER TOTAL KNEE REPLACEMENT AND TOTAL HIP REPLACEMENT

Marmarali B., Altintas F., Bal K., Bozkurt K., Demir M., Erdemli B., et al.
VALUE IN HEALTH , vol.15, no.4, 2012 (SCI-Expanded) identifier

The functional SLC11A1 gene polymorphisms are associated with sarcoidosis in Turkish population.

AKÇAKAYA P., AZEROGLU B., EVEN I., ATES O., TURKER H., Ongen G., et al.
Molecular biology reports , vol.39, pp.5009-16, 2012 (SCI-Expanded) identifier identifier identifier

Enoxaparin followed by once-weekly idrabiotaparinux versus enoxaparin plus warfarin for patients with acute symptomatic pulmonary embolism: a randomised, double-blind, double-dummy, non-inferiority trial

ÖNGEN H.
LANCET , vol.379, no.9811, pp.123-129, 2012 (SCI-Expanded) Sustainable Development

Venous Thromboembolism Risk and Thromboprophylaxis Among Hospitalized Patients: Data From the Turkish Arm of the ENDORSE Study

Ongen G., YILMAZ A., CIRAK A. K., ERSOY C. Y., Erden F., ALTINTAS F., et al.
CLINICAL AND APPLIED THROMBOSIS-HEMOSTASIS , vol.17, no.5, pp.539-545, 2011 (SCI-Expanded) identifier identifier identifier

Extrapulmonary involvement in patients with sarcoidosis in Turkey

Okumus G., Musellim B., Cetinkaya E., Turker H., Uzaslan E., Yenturk E., et al.
RESPIROLOGY , vol.16, no.3, pp.446-450, 2011 (SCI-Expanded) identifier identifier identifier

Venous thromboembolism risk and prophylaxis in hospitalised medically ill patients. The ENDORSE Global Survey.

ÖNGEN H.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS , vol.103, no.4, pp.736-748, 2010 (SCI-Expanded)

3p abnormalities in peripheral lymphocytes in small cell lung cancer

Tarkan-Arguden Y., Hacihanefioglu S., Ongen G., Erk M., Cenani A.
TUMORI , vol.95, no.4, pp.535-537, 2009 (SCI-Expanded) Sustainable Development identifier identifier identifier

NRAMP1 (SLC11A1): POSSIBLE CANDIDATE GENE FOR SARCOIDOSIS IN TURKISH POPULATION

Akcakaya P., Azeroglu B., Even I., Ates O., TURKER H., Ongen G., et al.
IUBMB LIFE , vol.61, no.3, pp.369-370, 2009 (SCI-Expanded) identifier

TNF GENE POLYMORPHISMS IN SARCOIDOSIS

Pamukcu C., Yalcin B., Ates O., Topal-Sarikaya A., TURKER H., Ongen G.
IUBMB LIFE , vol.61, no.3, pp.332-333, 2009 (SCI-Expanded) identifier

Association between 'interleukin' 10 gene (IL10) polymorphisms and systemic sclerosis with interstitial lung involvement

Ates O., Musellim B., Ongen G., Topal-Sarikaya A.
RHEUMATOLOGY INTERNATIONAL , vol.28, no.11, pp.1123-1126, 2008 (SCI-Expanded) identifier identifier identifier

Interleukin-10 and tumor necrosis factor-alpha gene polymorphisms in tuberculosis

Ates O., Musellim B., Ongen G., Topal-Sarikaya A.
JOURNAL OF CLINICAL IMMUNOLOGY , vol.28, no.3, pp.232-236, 2008 (SCI-Expanded) Sustainable Development identifier identifier identifier

NRAMP1 (SLC11A1): A plausible candidate gene for systemic sclerosis (SSc) with interstitial lung involvement

Ates O., Musellim B., Ongen G., Topal-Sarikaya A.
JOURNAL OF CLINICAL IMMUNOLOGY , vol.28, no.1, pp.73-77, 2008 (SCI-Expanded) identifier identifier identifier

The oxidant-antioxidant balance in systemic sclerosis cases with interstitial lung involvement

Musellim B., Ikitimur H., Uzun H., Ongen G.
RHEUMATOLOGY INTERNATIONAL , vol.27, no.2, pp.163-167, 2006 (SCI-Expanded) identifier identifier identifier

Comparison of extra-pulmonary and pulmonary tuberculosis cases: factors influencing the site of reactivation

Musellim B., Erturan S., Duman E., Ongen G.
INTERNATIONAL JOURNAL OF TUBERCULOSIS AND LUNG DISEASE , vol.9, no.11, pp.1220-1223, 2005 (SCI-Expanded) Sustainable Development identifier identifier identifier

Cytogenetic analysis of 11 squamous cell lung carcinomas

Tarkan-Arguden Y., Hacyhanefioolu S., Ongen G., Erk M., Cenani A.
CYTOGENETICS AND CELL GENETICS , vol.81, no.2, pp.157, 1998 (SCI-Expanded) identifier

Articles Published in Other Journals

Cytogenetic and FISH Examination of 3p Abnormalities in Lung Cancer Patients

Bakhshaliyeva N., ÇIRAKOĞLU A., Ongen H. G., Bil Tuncay E., ARGÜDEN Y.
Experimed , vol.14, no.1, pp.26-39, 2024 (Scopus) identifier

Diagnosis and Treatment Patterns of Chronic Thromboembolic Pulmonary Hypertension in Russia, Kazakhstan, Turkey, Lebanon, and Saudi Arabia: A Registry Study

Öngen H. G., AKDENİZ B., Düzenli M. A., Chernyavsky A., Dabar G., Idrees M., et al.
Drugs - Real World Outcomes , vol.11, no.1, pp.149-165, 2024 (ESCI) Creative Commons License identifier identifier

Assessment of atrial electromechanical delay and P wave dispersion in patients with chronic obstructive pulmonary disease

Cimci M., BÖREKÇİ Ş., KILIÇKIRAN AVCI B., Hysi E., Ongen H. G., KARADAĞ B., et al.
TURK KARDIYOLOJI DERNEGI ARSIVI-ARCHIVES OF THE TURKISH SOCIETY OF CARDIOLOGY , vol.48, no.3, pp.263-269, 2020 (ESCI) Sustainable Development identifier identifier identifier

Refereed Congress / Symposium Publications in Proceedings

COMPARISON OF DIFFERENT PULMONARY HYPERTENSION SCREENING ALGORITHMS IN PATIENTS WITH SYSTEMIC SCLEROSIS

Erdogan M., Avci B. K., Ebren C., Ersoy Y., Ongen Z., Ongen G., et al.
Annual European Congress of Rheumatology (EULAR), ELECTR NETWORK, 03 June 2020, vol.79, pp.698-699 identifier

PERFORMANCE OF DIFFERENT PULMONARY HYPERTENSION SCREENING ALGORITHMS IN PATIENTS WITH SYSTEMIC SCLEROSIS PATIENTS

Erdogan M., Avci B. K., Ersoy Y., Ebren C., Ongen Z., Ongen G., et al.
Annual European Congress of Rheumatology (EULAR), Madrid, Spain, 12 - 15 June 2019, vol.78, pp.842 identifier

Pulmoner arteryel hipertansiyonda serum lektin benzeri okside lipoprotein reseptöru¨-1’in endotel hasar belirteci olarak önemi ve hemodinamik parametreler ile olan iliskisi (SB-116)

UZUN H., YAŞAR İ., İKİTİMUR B., KILIÇKIRAN AVCI B., Güntaş Korkmaz G., ATAHAN E., et al.
30. Uluslararası Katılımlı Tu¨rk Kardiyoloji Kongresi, Antalya, Turkey, 23 - 26 October 2014, vol.14, pp.36

Predictors of long term survival in patients with pulmonary arterial hypertension

YURTSEVEN E., KILIÇKIRAN AVCI B., İKİTİMUR B., KARADAĞ B., ÖZCAN S., ATAHAN E., et al.
30. Uluslararası Katılımlı Tu¨rk Kardiyoloji Kongresi, Antalya, Turkey, 23 - 26 October 2014, vol.14, pp.37

Pulmoner Arteryel Hipertansiyonda Vitamin D ve Paratiroid Hormon Du¨zeyleri

Güntaş G., UZUN H., YAŞAR İ., Irmak H., İKİTİMUR B., ATAHAN E., et al.
Tu¨rkiye Solunum Arastırmaları Dernegi 35. Ulusal Kongresi, Solunum 2013, İzmir, Turkey, 2 - 06 October 2013, pp.17

Pulmoner arteryel hipertansiyonda oksidatif stres parametreleri ile hemodinamik parametreler arasındaki iliski (SS-017)

UZUN H., KILIÇKIRAN AVCI B., YAŞAR İ., Güntaş Korkmaz G., İKİTİMUR B., ATAHAN E., et al.
Tu¨rkiye Solunum Arastırmaları Dernegi 35. Ulusal Kongresi, Solunum 2013, İzmir, Turkey, 2 - 06 October 2013, pp.20

SKLERODERMA HASTALARINDA 'DYSANAPSIS'

MÜSELLİM B., ENŞEN N., ÖNGEN H.
ÜRK FİZYOLOJİK BİLİMLER DERNEĞİ XXXII. ULUSAL FİZYOLOJİ KONGRESİ (Uluslararası Katılımlı), Denizli, Turkey, 18 - 22 September 2006, no.2, pp.89

Polymorphism of SLC11A1 gene confers susceptibility to systemic sclerosis

ATES O., MUSELLIM B., Ongen G., TOPAL-SARIKAYA A.
31st Congress of the Federation-of-European-Biochemical-Societies (FEBS), İstanbul, Turkey, 24 - 29 June 2006, vol.273, pp.273-274 identifier

The possible association between systemic sclerosis and FokI, BsmI, TaqI polymorphisms in VDR

ATES O., DOLEK B., GUZ-EROGLU S., MUSELLIM B., Ongen G., TOPAL-SARIKAYA A.
31st Congress of the Federation-of-European-Biochemical-Societies (FEBS), İstanbul, Turkey, 24 - 29 June 2006, vol.273, pp.275 identifier

3p abnormalities in peripheral lymphocytes of a SCLC patient

TARKAN ARGÜDEN Y., Hacıhanefioğlu S., ÖNGEN H., Erk M., Cenani A.
14th International Chromosome Conference, Germany, pp.159

Cytogenetic analysis of 11 squamous cell lung carcinomas

TARKAN ARGÜDEN Y., Hacıhanefioğlu S., ÖNGEN H. G., Erk M., Cenani A.
13th International Chromosome Conference, Italy, 1 - 04 September 1998, pp.197

The correlation between the clinical signs of pulmonary embolism and the lung scanning with high and intermediate probability

Ongen G., Musellim B., Erk M., Umut S., Kucukusta A., Onsel C.
1st Mediterranean Congress on Interventional Diagnosis for Thorax Diseases, RHODES, Greece, 25 - 29 May 1996, pp.657-660 identifier

Metrics

Publication

48

Citation (WoS)

178

H-Index (WoS)

7

Citation (Scopus)

203

H-Index (Scopus)

8

Project

2

Open Access

1
UN Sustainable Development Goals